Core Scientific, Inc. Form 8-K Summary
Business Context and Reporting Period
Core Scientific, Inc. filed a Form 8-K reporting an executive appointment. The earliest reported event occurred on November 9, 2022; the filing was signed November 15, 2022. The company is incorporated in Delaware and its common stock and warrants trade on Nasdaq under CORZ and CORZW, respectively.
Executive Appointment
- Effective November 14, 2022, the board appointed Todd DuChene as President and Chief Legal Officer.
- DuChene had served as Executive Vice President, General Counsel, Chief Compliance Officer and Secretary since January 2022.
- He previously served as General Counsel and Secretary of Core Scientific Holding Co. from April 2019 until its merger with Power & Digital Infrastructure Acquisition Corp.
- The filing states that he has no family relationship with any director or executive officer, no reportable related-party transactions, and no undisclosed arrangements relating to his selection.
Financial Metrics and Liquidity
This filing does not provide revenue, profit, cash flow, margin, debt, liquidity, balance-sheet or other operating financial metrics.
Material Changes, Outlook and Risks
The material change reported is the expansion of Todd DuChene’s responsibilities to include President in addition to Chief Legal Officer. The filing provides no financial guidance, operating outlook, management commentary, contingencies or unusual financial items.
Facts Investors Should Verify
- Confirm the effective date and scope of DuChene’s President and Chief Legal Officer responsibilities.
- Review subsequent filings for additional executive changes, compensation terms or governance developments.
- Consult the company’s periodic reports for financial condition, liquidity, debt obligations and operating performance, which are not addressed in this 8-K.